0
Skip to Content
C2N Diagnostics
Board of Managers
Our Team
Clinical Use
Research & Trials
Science
Clinical Diagnostics
Bioanalytical Services
International Partners
Contact Us
Careers
News Releases
Media Coverage
Videos
Newsletters
Webinars
Frequently Asked Questions
Precivity™ Tests
C2N Diagnostics
Board of Managers
Our Team
Clinical Use
Research & Trials
Science
Clinical Diagnostics
Bioanalytical Services
International Partners
Contact Us
Careers
News Releases
Media Coverage
Videos
Newsletters
Webinars
Frequently Asked Questions
Precivity™ Tests
Folder: About
Back
Board of Managers
Our Team
Folder: Publications
Back
Clinical Use
Research & Trials
Science
Folder: Products
Back
Clinical Diagnostics
Bioanalytical Services
International Partners
Folder: Contact
Back
Contact Us
Careers
Folder: News
Back
News Releases
Media Coverage
Videos
Newsletters
Webinars
Frequently Asked Questions
Precivity™ Tests

Medical Device Network: C2N’s Precivity blood biomarker shows promise in Alzheimer’s screening

Nov 8
Written by Joni Henderson
Read more
Joni Henderson
Previous
Previous

NPR: Blood tests can help diagnose Alzheimer’s - if they’re accurate enough. Not all are
Next
Next

Medscape: Novel Tau Blood Biomarker Shows Promise
No results found

C2N Diagnostics

4340 Duncan Avenue
St. Louis, MO 63110

Contact us

©2026 C2N Diagnostics. All rights reserved.

Info

Privacy Policy

Terms of Use

HIPAA Policy

California
Declaration of Compliance